Eiger Biopharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Eiger Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eiger Biopharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eiger Biopharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $522 | 2.3k | 0.23 |
| 2023-09-30 | $706 | 2.3k | 0.30 |
| 2023-06-30 | $3.4k | 4.9k | 0.70 |
| 2023-03-31 | $50k | 56k | 0.90 |
| 2022-12-31 | $64k | 54k | 1.19 |
| 2022-09-30 | $409k | 54k | 7.52 |
| 2022-06-30 | $321k | 51k | 6.29 |
| 2022-03-31 | $316k | 38k | 8.29 |
| 2021-12-31 | $202k | 39k | 5.19 |
| 2021-09-30 | $264k | 40k | 6.68 |
| 2021-06-30 | $328k | 39k | 8.53 |
| 2021-03-31 | $234k | 27k | 8.83 |
| 2020-12-31 | $345k | 28k | 12.29 |
| 2020-09-30 | $201k | 25k | 8.16 |
| 2020-06-30 | $263k | 27k | 9.59 |
| 2020-03-31 | $151k | 22k | 6.80 |
| 2019-12-31 | $340k | 23k | 14.91 |
| 2019-09-30 | $221k | 22k | 10.25 |
| 2019-06-30 | $223k | 21k | 10.60 |